REPL vs AMGN: Which Stock is Better?

Side-by-side comparison of Replimune Group Inc and Amgen Inc in 2026

Comparison Updated:

REPL

Replimune Group Inc

AMGN

Amgen Inc

$351.43

Key Metrics Comparison

MetricREPLAMGNWinner
Market Cap$825.73M$188.67BAMGN
P/E RatioN/A24.33AMGN
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze REPL

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is REPL or AMGN a better investment?

Comparing REPL and AMGN: Replimune Group Inc has a market cap of $825.73M while Amgen Inc has $188.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between REPL and AMGN?

REPL (Replimune Group Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: REPL or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: REPL or AMGN?

Both REPL and AMGN show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: REPL or AMGN?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: REPL or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $188.67B compared to $825.73M for REPL.

Should I buy REPL or AMGN in 2026?

Both REPL and AMGN have investment merit. REPL trades at $N/A while AMGN trades at $351.43. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between REPL and AMGN stock?

Key differences: Market Cap ($825.73M vs $188.67B), P/E Ratio (N/A vs 24.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy REPL or AMGN in 2026?

The choice between REPL and AMGN depends on your investment goals. AMGN shows higher revenue growth (0.0%). AMGN has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between REPL and AMGN?

REPL (Replimune Group Inc) has a market cap of $825.73M, while AMGN (Amgen Inc) has a market cap of $188.67B. AMGN is the larger company by market value.

Popular Stock Comparisons